Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma
Clinical trial NCT03503630 · UNKNOWN
Trial details
- NCT number
- NCT03503630
- Sponsor
- Ali Shamseddine
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-20
- Primary completion
- 2021-03-15
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.